| Previous Close | 39.84 |
| Open | 39.71 |
| Bid | 39.92 x 100 |
| Ask | 40.05 x 200 |
| Day's Range | 39.60 - 40.34 |
| 52 Week Range | 22.45 - 40.48 |
| Volume | 23,841 |
| Avg. Volume | 261,331 |
| Market Cap | 1.36B |
| Beta | 1.11 |
| PE Ratio (TTM) | 105.49 |
| EPS (TTM) | 0.38 |
| Earnings Date | Aug 2, 2017 - Aug 7, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 40.00 |
- Investopedia•2 days ago
Top 3 Healthcare Penny Stocks for 2017
These three penny health care stocks are poised for a positive 2017.
- Capital Cube•3 days ago
ETFs with exposure to Repligen Corp. : June 19, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Repligen Corp. Here are 5 ETFs with the largest exposure to RGEN-US. Comparing the performance and risk of Repligen Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Capital Cube•6 days agoRepligen Corp. :RGEN-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017
Categories: Yahoo FinanceGet free summary analysis Repligen Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Repligen Corp. – Novavax, Inc., Neurocrine Biosciences, Inc., BioMarin Pharmaceutical Inc., General Electric Company, Thermo Fisher Scientific Inc., Caladrius Biosciences, Inc., Pfizer Inc., Sangamo Therapeutics, Inc., Charles River Laboratories ... Read more (Read more...)